B. Braun Medical has issued a voluntary nationwide recall of Heparin sodium injection solution due to the presence of a heparin-like contaminant.
The recall affects 23 Finished Product lots, which were supplied by Scientific Protein Laboratories (SPL). The FDA has received reports of serious
injuries and/or deaths in patients who have been administered heparin injectable products of other companies containing this contaminant.